“I don’t need a vaccine because we have treatments now.”
That’s like saying “I’m not wearing a seatbelt because doctors can fix broken bones if I get in a crash.”
Why risk injury in the first place?
Here we explain treatments you might have heard about in the news:
- Paxlovid
- Remdesivir
- Monoclonal antibodies
They’re great tools that we didn’t have before, but nothing is perfect.
Share our original Tweet!
“We’ve got treatments now…”
…Is a bad reason to skip out on COVID-19 shots.
Let’s talk treatments ⬇️#ScienceUpFirst
[1/10] pic.twitter.com/m0MsuKtyZu
— ScienceUpFirst | LaScienced’Abord (@ScienceUpFirst) April 20, 2022
View our original Instagram Post!
View this post on Instagram
Sources
- Details for: PAXLOVID – COVID-19
- Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know – Ontario COVID-19 Science Advisory Table
- Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19
- Details for: VEKLURY – COVID-19
- New study shows why remdesivir works against SARS-CoV-2 but not on other viruses like the flu
- Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
- hDetails for: SOTROVIMAB FOR INJECTION – COVID-19
- Details for: CASIRIVIMAB AND IMDEVIMAB – COVID-19
- Details for: BAMLANIVIMAB – Authorized By Interim Order / Autorisée par arrêté d’urgence – COVID-19
- Monoclonal Antibodies for COVID-19 | Patient Information
- Outpatient therapy for COVID-19: What are the options and who is eligible?
- Treatment options for immunocompromised Albertans explored as tough subvariant takes hold | CBC News
